Work

1791P A phase I pharmacology study of the dual MDMX/MDM2 inhibitor, ALRN 6924, in healthy volunteers

Year: 2021

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.1734

Authors: C. Voors-Pette, W. Aalders, M. Brill, D. Ferrari, A. Annis, U. Steidl, M. Aivado, V. Vukovic

Institutions: QPS (Netherlands), Aileron (United States), Albert Einstein College of Medicine

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

OpenAlex ID: W3202548245

FWCI: 0.182

Cites:

Cited by: 2

Related to: 10